Glimrok MV 1mg/500mg/0.2mg Tablet SR
Marketer
Wood Rock Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimrok MV 1mg/500mg/0.2mg Tablet SR
Diabex Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with controlled glucose levels or well-being; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating dietary adjustments, physical activity, and weight management as directed by your doctor. Lifestyle modifications are crucial for effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and treat these symptoms promptly. Maintain regular meals and carry a readily available fast-acting carbohydrate source, such as glucose tablets or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before initiating therapy. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Glimrok MV 1mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glimrok MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimrok MV 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.
Common Side effects of Glimrok MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimrok MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the Glimrok MV 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.
How Glimrok MV 1mg/500mg/0.2mg Tablet SR works:
Glimrok MV extended-release tablets (1mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimrok MV 1mg/500mg/0.2mg Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimrok MV 1mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimrok MV 1mg/500mg/0.2mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such conditions arise.
KidneyUNSAFE
The use of Glimrok MV 1mg/500mg/0.2mg Tablet SR is likely unsafe for individuals with kidney impairment and should be disregarded. Medical advice is necessary. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimrok MV 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate hepatic dysfunction, a low initial dose is usually prescribed; however, its use is contraindicated in patients with severe liver disease.
What if you forget to take Glimrok MV 1mg/500mg/0.2mg Tablet SR :
Should you forget a Glimrok MV 1mg/500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimrok MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently